Pathologic practice standards for breast carcinoma: Tumor size, reliable data, or miscues?

Journal of the American College of Surgeons

Volumn 196, Issue 1, 2003, Pages 91-92

  Lagios, Michael D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; EDITORIAL; HUMAN; MEDICAL SOCIETY; PATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GUIDELINE ADHERENCE; HUMANS; NEOPLASM STAGING; PATHOLOGY, SURGICAL; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE;

EID: 0037229608     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01540-5     Document Type: Editorial

References (6)

1. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002;95:713-723.
2. Wilkinson NW, Shahryarinejad A, Winston JS, et al. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg 2003;196:38-44.
3. International Breast Cancer Consensus Conference. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg 2001;193:297-302.
4. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen and chemotherapy for lymph-node-negative, estrogen-receptor-positive breast carcinoma. JNCI 1997;89:1673-1682.
5. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-1319.
6. Fisher B, Dignam J, Tan-Chu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B17. Cancer 1999;86:429-438.